DNA Methylation and Birth Weight: a Genome-wide Analysis

Area of Science:

• Epigenetics
• Metabolic Health
• Developmental Biology

Background:

• Birth weight is a critical indicator of infant health and development.
• Epigenetic modifications, such as DNA methylation, play a role in gene regulation.
• Variations in DNA methylation have been associated with various health outcomes.

Purpose of the Study:

• To investigate the correlation between global DNA methylation patterns and infant birth weight.
• To identify specific differentially methylated CpG sites and associated signaling pathways.
• To explore the role of these methylation changes in the fetal programming of diabetes.

Main Methods:

• Infant birth weight was used to categorize cases and controls.
• Cord blood and placental samples were collected for analysis.
• DNA methylation profiling was performed using bisulphite-converted DNA.

Main Results:

• Numerous differentially methylated CpG sites were identified.
• These sites are involved in hundreds of signaling pathways.
• Over ten pathways related to glucose and lipid metabolism were identified, including the insulin-signaling pathway (ISP), adipocytokine signaling pathway (ASP), and MAPK signaling pathway.

Conclusions:

• Global DNA methylation variations are significantly correlated with infant birth weight.
• Aberrant DNA methylation in key metabolic and signaling pathways may contribute to the fetal programming of diabetes.
• These findings highlight the importance of epigenetic regulation in early development and metabolic health.